CALIXAR will be present at the 4th Congress of Immunotherapies & Innovations for Infectious Diseases on December 9-10, 2020

CALIXAR team will participate at the 4th Congress of Immunotherapies & Innovations for Infectious Diseases to meet partners working on this thematic and exchange about strategies and scientific issues tied up on its activities.

CALIXAR is a biotech company specialized in the isolation of native membrane therapeutic targets and antigens. This digital event will be the opportunity to present CALIXAR’s proprietary technologies and know-how to any partner who wants to contribute to generate drugs, antibodies or vaccines to fight infectious diseases.

About I4ID2020:

The purpose of this two-day congress is to foster interactions between pharmaceutical industries, research labs, service providers, technology developers, and clinicians, thereby contributing to the development of innovative strategies against infectious diseases in a multidisciplinary approach. The I4ID2020 edition will largely address the current COVID-19 pandemics as well as other infectious diseases.

For more information: https://www.i4id.org/

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin